Pradaxa
Prevention of strokes and blood clots in patients with abnormal heart rhythm (atrial fibrillation).
Primary prevention of venous thrombo-embolic events (VTE) in adults after elective total hip or knee replacement surgery.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and secondary prevention of recurrent DVT and PE in adults.